145 related articles for article (PubMed ID: 17371490)
1. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.
Schneppenheim R; Castaman G; Federici AB; Kreuz W; Marschalek R; Oldenburg J; Oyen F; Budde U
J Thromb Haemost; 2007 Apr; 5(4):722-8. PubMed ID: 17371490
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity of severe von Willebrand disease type III in the German population.
Schneppenheim R; Krey S; Bergmann F; Bock D; Budde U; Lange M; Linde R; Mittler U; Meili E; Mertes G
Hum Genet; 1994 Dec; 94(6):640-52. PubMed ID: 7989040
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.
Ahmad F; Budde U; Jan R; Oyen F; Kannan M; Saxena R; Schneppenheim R
Thromb Haemost; 2013 Apr; 109(4):652-60. PubMed ID: 23407766
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the olfactory function in Italian patients with type 3 von Willebrand disease caused by a homozygous 253 Kb deletion involving VWF and TMEM16B/ANO2.
Cenedese V; Mezzavilla M; Morgan A; Marino R; Ettorre CP; Margaglione M; Gasparini P; Menini A
PLoS One; 2015; 10(1):e0116483. PubMed ID: 25635880
[TBL] [Abstract][Full Text] [Related]
5. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.
Hampshire DJ; Abuzenadah AM; Cartwright A; Al-Shammari NS; Coyle RE; Eckert M; Al-Buhairan AM; Messenger SL; Budde U; Gürsel T; Ingerslev J; Peake IR; Goodeve AC
Thromb Haemost; 2013 Aug; 110(2):264-74. PubMed ID: 23702511
[TBL] [Abstract][Full Text] [Related]
7. A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions.
Xie F; Wang X; Cooper DN; Chuzhanova N; Fang Y; Cai X; Wang Z; Wang H
Blood Cells Mol Dis; 2006; 36(3):385-91. PubMed ID: 16690331
[TBL] [Abstract][Full Text] [Related]
8. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
9. Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual.
Peake IR; Liddell MB; Moodie P; Standen G; Mancuso DJ; Tuley EA; Westfield LA; Sorace JM; Sadler JE; Verweij CL
Blood; 1990 Feb; 75(3):654-61. PubMed ID: 2297569
[TBL] [Abstract][Full Text] [Related]
10. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
11. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
13. Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease.
Gaucher C; Diéval J; Mazurier C
Blood; 1994 Aug; 84(4):1024-30. PubMed ID: 8049421
[TBL] [Abstract][Full Text] [Related]
14. An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary.
Mohl A; Marschalek R; Masszi T; Nagy E; Obser T; Oyen F; Sallai K; Bodó I; Schneppenheim R
J Thromb Haemost; 2008 Oct; 6(10):1729-35. PubMed ID: 18665926
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
16. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
[TBL] [Abstract][Full Text] [Related]
17. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.
Ngo KY; Glotz VT; Koziol JA; Lynch DC; Gitschier J; Ranieri P; Ciavarella N; Ruggeri ZM; Zimmerman TS
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2753-7. PubMed ID: 3258663
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.
Cumming A; Grundy P; Keeney S; Lester W; Enayat S; Guilliatt A; Bowen D; Pasi J; Keeling D; Hill F; Bolton-Maggs PH; Hay C; Collins P;
Thromb Haemost; 2006 Nov; 96(5):630-41. PubMed ID: 17080221
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand Disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families.
Schneppenheim R; Federici AB; Budde U; Castaman G; Drewke E; Krey S; Mannucci PM; Riesen G; Rodeghiero F; Zieger B; Zimmermann R
Thromb Haemost; 2000 Jan; 83(1):136-40. PubMed ID: 10669167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
